Riddhi Siddhi Gluco Biols gave notice of a board meeting on November 5, 2026 to consider Q2 and half-year unaudited results. The trading window stays closed until 48 hours after results.
Riddhi Siddhi Gluco Biols Limited has shifted its registered office from Gujarat to Haryana. Consequently, the company's Corporate Identification Number (CIN) has been updated.
Riddhi Siddhi Gluco Biols Limited has appointed Taral Shah as a Non-Executive Independent Director. Additionally, the company appointed Batliboi & Purohit as its new Statutory Auditor.
Riddhi Siddhi Gluco Biols Limited conducted its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact items listed in the AGM notice.
Riddhi Siddhi Gluco Biols Limited has issued a notice for its 35th Annual General Meeting on September 25, 2026. The agenda includes financial approvals and business resolutions.
Riddhi Siddhi Gluco Biols Limited appointed Taral Shah as Independent Director and re-appointed Batliboi & Purohit as Statutory Auditor, following a board meeting.
The company announced the outcome of its August 31, 2026 Board meeting. Key decisions included appointing an Additional Independent Director and approving the 35th AGM notice.
Riddhi Siddhi Gluco Biols Ltd sold 823,422 shares via an offer-for-sale by promoter Vital Connections LLP. The deal trims promoter stake to meet SEBI public‑shareholding norms.
Riddhi Siddhi Gluco Biols revised its OFS seller to Vital Connections LLP for MPS compliance. The change does not affect the share volume or post-OFS structure.
Riddhi Siddhi Gluco Biols issued a postal ballot notice seeking shareholder approval for shifting its registered office and altering its Memorandum of Association. E-voting concludes July 3, 2026.
Riddhi Siddhi Gluco Biols issued a corrigendum to its FY2026 results to include missing ₹0.40 Crore tax asset figures. This correction ensures accurate financial reporting.
Riddhi Siddhi Gluco Biols rescheduled its May 19 board meeting to May 25, 2026. The meeting will consider audited financial results for the 2026 fiscal year.
Riddhi Siddhi Gluco Biols scheduled a board meeting on May 19, 2026. Directors will consider FY2026 audited financial results and potential equity dividend recommendations.
Riddhi Siddhi Gluco Biols Limited disclosed that it does not qualify as a 'Large Corporate' under SEBI's debt-raising framework. As of March 31, 2026, the company reported outstanding borrowings of ₹167.07 Crore and holds a CRISIL BBB- credit rating.
Riddhi Siddhi Gluco Biols Ltd (RSGBL) has completed the acquisition of Cargill’s corn wet milling facility in Davangere, Karnataka. The plant has an annual capacity of 300,000 MT. This strategic move strengthens RSGBL's manufacturing capabilities in the starch and derivatives industry and expands its footprint in southern India.
Riddhi Siddhi Gluco Biols Limited has completed the acquisition of identified assets from Cargill India Pvt. Ltd. The transaction includes a manufacturing facility in Southern India, land, infrastructure, warehouses, and corn silos. This acquisition significantly strengthens the company's operational footprint in the region.
Riddhi Siddhi Gluco Biols promoter Mr. Ganpatraj Chowdhary intends to sell 8,23,422 shares (11.55% stake) via an Offer for Sale (OFS). This transaction aims to comply with Minimum Public Shareholding (MPS) norms following a Securities Appellate Tribunal order. The move will increase public shareholding to the mandated 25%.